NASDAQ:FDMT
4D Molecular Therapeutics Inc
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.4dmoleculartherapeutics.comipo date
Dec 11, 2020
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1...Show More
Earnings
Earnings Release in 11 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus